Summary of all death's or all age's and all causes from the vaccine monitored group
Kiwi made this Official Information request to Ministry of Health
This request has an unknown status. We're waiting for Kiwi to read a recent response and update the status.
From: Kiwi
Dear Ministry of Health,
On medsafe's website it list's total number of death's per age following the vaccine 1 shot..
The information for age's 16 -59 are missing aswell as the last 3 months
1 We request the data on death's from the monitored vaccinated group in NZ.. No matter the age or cause of deaths. Vaccine related or not..
We only need numbers and age group..No names or private data. And only following 1 month of vaccine shot 1 and 2
2 How many vaccines has NZ govt administrated in the pacific Islands? Ie tonga, somoa, cook island and all that we manager
Yours faithfully,
Kiwi
From: OIA Requests
Kia ora,
Thank you for your request for official information received on 3 October
2021 for:
"What is your definition of someone having 1 shot of vaccine and someone
having 2 shots?
Who negotiated on NZ behalf the contract with pfizer for the covid 19
vaccine?
What tests if any did medsafe do on the vaccine?
What lobby company's/firm's NGO's or such lobby the NZ government on
pfizer's behalf?
Why did medsafe 1st decline to approve the vaccine the 1st time it was
submitted to medsafe?
Why was the prescription requirement ignored?
Why is medsafe/Ministry of health hiding the benefits of ivermectin??
Who is responsible for managing the pfizer NZ govt contract for covid 19
vaccine?”
A secondary request for official information was received on 3 October
2021 for:
“On medsafe's website it list's total number of death's per age following
the vaccine 1 shot..
The information for age's 16 -59 are missing aswell as the last 3 months
1 We request the data on death's from the monitored vaccinated group in
NZ.. No matter the age or cause of deaths. Vaccine related or not..
We only need numbers and age group..No names or private data. And only
following 1 month of vaccine shot 1 and 2
2 How many vaccines has NZ govt administrated in the pacific Islands? Ie
tonga, somoa, cook island and all that we manager”
The Ministry of Health has consolidated your request under reference
number: H202113498.
As required under the Official Information Act 1982, the Ministry will
endeavour to respond to your request no later than 4 October 2021, being
20 working days after the day your request was received.
Due to the COVID-19 global pandemic response, the Ministry is experiencing
significantly higher volumes of queries and requests for information. If
we are unable to respond to your request within this time frame, we will
notify you of an extension of that time frame.
If you have any queries related to this request, please do not hesitate to
get in touch.
Ngâ mihi
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [1][email address]
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. mailto:[email address]
hide quoted sections
victor left an annotation ()
baseline underreporting rate being used in the background rates comparison.
There can't be a meaningful background rates comparison.
Baseline underreporting rate must be made public because there is an underreporting rate.
On top of this using background rates (population cohort) which have not been injected with comirnaty mrna is beyond farce.
Comparing those injected with comirnaty mrna against those not injected with comirnaty mrna and stating 'comirnaty injected groups experience improved all cause mortality' versus the group not injected with comirnaty mrna.
Is what MEDSAFE summary reports are stating in written word.
"To date, the observed number of deaths reported after vaccination is actually less than the expected number of natural deaths"
[Injected with comirnaty mrna offers improvement in all cause mortality (background rates)]
1. Underreporting baseline rate
2. Comparison of comirnaty mrna against non comirnaty mrna injected
From: OIA Requests
Kia ora Kiwi,
Please find attached a response to your official information act request
Ngā mihi
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [1][email address]
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. mailto:[email address]
hide quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
victor left an annotation ()
The single solitary classification of 'likely' for mycocarditis of female 50+
Methodology for the process leading to classification of 'likely' requires transparency.
Equally then the methodology for how 17y female classification of 'unlikely' was arrived at both having had the same product injected into their body.
Assessment methodology the process the people and the flows are currently and unsubstantiated black box for which pieces can be garnered.
OIA for full methodology including people process and all tools and frameworks involved in the process.
50s female mycocarditis - Likely
17 female blood clots - Unlikely
Comparative transparency analysis can then proceed to shine light into the blackness of this space.
Link to this